Rona Anhalt - EQRx Chief Officer
| EQRXDelisted Stock | USD 1.83 0.13 6.63% |
Insider
Rona Anhalt is Chief Officer of EQRx Inc
| Age | 58 |
| Phone | 617 315 2255 |
| Web | https://www.eqrx.com |
Rona Anhalt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Rona Anhalt against EQRx stock is an integral part of due diligence when investing in EQRx. Rona Anhalt insider activity provides valuable insight into whether EQRx is net buyers or sellers over its current business cycle. Note, EQRx insiders must abide by specific rules, including filing SEC forms every time they buy or sell EQRx'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Rona Anhalt over three weeks ago Acquisition by Rona Anhalt of 21440 shares of Certara subject to Rule 16b-3 |
EQRx Management Efficiency
The company has return on total asset (ROA) of (0.1379) % which means that it has lost $0.1379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2025) %, meaning that it created substantial loss on money invested by shareholders. EQRx's management efficiency ratios could be used to measure how well EQRx manages its routine affairs as well as how well it operates its assets and liabilities.EQRx Inc currently holds 3.83 M in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. EQRx Inc has a current ratio of 28.18, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about EQRx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Isabel Aznarez | Stoke Therapeutics | 52 | |
| Bill DeGrado | Pliant Therapeutics | N/A | |
| Wei MD | Erasca Inc | 54 | |
| Hal MD | Pliant Therapeutics | N/A | |
| Thomas Catinazzo | Relay Therapeutics | 47 | |
| Alexis AM | Blueprint Medicines Corp | 52 | |
| Crystal MD | Lyell Immunopharma | 63 | |
| Silvia Buonamici | Monte Rosa Therapeutics | N/A | |
| Craig Muir | Pliant Therapeutics | N/A | |
| MD MBA | Pliant Therapeutics | 47 | |
| Jack Anders | Revolution Medicines | 47 | |
| Elizabeth Montgomery | Black Diamond Therapeutics | 52 | |
| Michael Carruthers | Edgewise Therapeutics | 66 | |
| JD MBA | Monte Rosa Therapeutics | 46 | |
| Path FRCP | Revolution Medicines | 61 | |
| David Epstein | Black Diamond Therapeutics | 65 | |
| Elizabeth Homans | Lyell Immunopharma | 58 | |
| David MD | Erasca Inc | 40 | |
| John Castle | Monte Rosa Therapeutics | 53 | |
| Nello MD | Kymera Therapeutics | 45 | |
| JD Esq | Black Diamond Therapeutics | 59 | |
Management Performance
| Return On Equity | -0.2 | |||
| Return On Asset | -0.14 |
EQRx Inc Leadership Team
Elected by the shareholders, the EQRx's board of directors comprises two types of representatives: EQRx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EQRx. The board's role is to monitor EQRx's management team and ensure that shareholders' interests are well served. EQRx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EQRx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Hoey, Chief Operations | ||
| Robert LLB, CoFounder Advisor | ||
| Alexis AM, Founder Directors | ||
| MAPP MD, CoFounder Advisor | ||
| Jamilu Rubin, Chief Officer | ||
| Sir CBE, CoFounder Advisor | ||
| Rona Anhalt, Chief Officer | ||
| Eric MD, Chief Exec | ||
| Melanie Nallicheri, CEO Director | ||
| Dina JD, Gen Sec |
EQRx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EQRx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.14 | |||
| Current Valuation | (75.06 M) | |||
| Shares Outstanding | 487.7 M | |||
| Shares Owned By Insiders | 11.13 % | |||
| Shares Owned By Institutions | 68.24 % | |||
| Number Of Shares Shorted | 11.3 M | |||
| Price To Book | 1.00 X | |||
| EBITDA | (517.58 M) | |||
| Net Income | (169.09 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in EQRx Stock
If you are still planning to invest in EQRx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EQRx's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |